Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Cancelled Pre Market
Current status date:
2016-05-05
Original market date: See footnote 1
Product name:
ENALAPRIL/HCTZ
DIN:
02398478
Product Monograph/Veterinary Labelling:
Date:
2016-03-21
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
FROSST A DIVISION OF MERCK CANADA INC
16750 Route Transcanadienne
Kirkland
Quebec
Canada
H9H 4M7
Class:
Human
Dosage form(s):
Tablet
Route(s) of administration:
Oral
Number of active ingredient(s):
2
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
24:32.04 , 40:28.20
Anatomical Therapeutic Chemical (ATC): See footnote 4
C09BA02 ENALAPRIL AND DIURETICS
Active ingredient group (AIG) number:See footnote5
0252326001
| Active ingredient(s) | Strength |
|---|---|
| ENALAPRIL SODIUM | 8 MG |
| HYDROCHLOROTHIAZIDE | 25 MG |